| Literature DB >> 27741320 |
Islay Mactaggart1, Hannah Kuper1, G V S Murthy2, Joseph Oye3, Sarah Polack1.
Abstract
PURPOSE: To investigate the relationship between two distinct measures of disability: self-reported functional limitations and objectively-screened clinical impairments.Entities:
Mesh:
Year: 2016 PMID: 27741320 PMCID: PMC5065175 DOI: 10.1371/journal.pone.0164470
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1The ICF.
Impairment and Health Condition Screening, Examination and Case Definition Criteria.
| Tool | Stage | Age | Method | Severity Thresholds | |
|---|---|---|---|---|---|
| SRFL | UNICEF/ Washington Group Module on Child Functioning & Disability[ | 0–1 | None | - | |
| 2–7 | Caregiver report on 12 functional domains assessed on reported severity scale of limitation in completing activities related to domain | Response categories: i) No difficulty; ii) Some difficulty; iii) A lot of difficulty; iv) Cannot do | |||
| I: 8–17 C: 8–20 | As above; self report in caregiver presence | ||||
| Washington Group Extended Set on Functioning [ | I: 18+ C:21+ | 14 functional domains assessed on reported severity scale of limitation in completing activities related to domain; self report | |||
| V | Adapted Rapid Assessment of Avoidable Blindness (RAAB) [ | <2 | Fix and Follow | Cannot fix and follow | |
| 2–4 | Finger counting | Cannot count fingers | |||
| 5+ | Visual Acuity (VA) (presenting and pinhole if VA <6/18) measured via tumbling ‘E’ chart | Presenting vision in better eye: i)No impairment: VA ≥ 6/18; ii) Moderate: VA<6/18 but ≥6/60; iii) Severe: VA <6/60 but ≥3/60; iv) Profound (blind): VA<3/60 | |||
| All ages | Examination to determine cause using direct ophthalmoscope by ophthalmic nurse (Cameroon) or ophthalmic assistant (India) if meet impairment criteria | ||||
| H | WHO Ear and Hearing Disorders Examination Protocol[ | 0–3 | Oto-Acoustic Emissions (OAE) Test | OAE Test Failure in both ears | |
| 4+ | OAE Test followed by Pure Tone Audiometry if OAE fails in both ears | Audiometry reading in better ear: | |||
| Children (4–17): i) No impairment: <35dBA; ii) Moderate: 35-60dBA; iii) Severe: 61-80dBA; iv) Profound (deaf): >80dBA | |||||
| Adults: i) No impairment: <41dBA; ii) Moderate: 41-60dBA; iii) Severe: 61-80dBA; iv) Profound (deaf): >80dBA | |||||
| All ages | Otoscopy examination to determine cause by an ENT Nurse (Cameroon) or audiologist (India) if meet impairment criteria | ||||
| MSI | Rapid Assessment of Musculoskeletal Impairment (RAM) [ | 0–7 | Caregiver report 6 questionss | Physiotherapist observed effects on the ability of the musculoskeletal system to function as a whole, categorised as: i) No impairment; ii) Mild; iii) Moderate; iv) Severe | |
| 8+ | As above; self report | ||||
| All ages | Examination by physiotherapist including standardised observation of activities | ||||
| E | (RAM) [ | 0–7 | Caregiver report of 3 questions to assess frequency and type of seizure activity | Reported three or more generalised tonic-clonic seizures in the past 12 months | |
| 8+ | As above; self report | ||||
| D | Patient Health Questionnaire (PHQ9) [ | 18+ | Three self-reported screening questions with a further six questions if screen is positive | Composite score: i) None: 0–4; ii) Mild: 10–14; iii) Moderately Severe: 15–19; iv) Severe: 20–27 | |
Column 1 acronyms: SRFL–self reported functional limitation; V–visual impairment; H–hearing impairment; MSI–musculoskeletal impairment; E–Epilepsy; D–depression
1No tools for this age group available
2In India, a seventh question on chronic back pain was added
Sample age and sex characteristics in Cameroon and India.
| Cameroon | India | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Males | Females | Total | Males | Females | Total | |||||||
| Age group (years) | n | % | n | % | n | % | n | % | n | % | n | % |
| 0–9 | 609 | 42 | 630 | 30 | 1,239 | 35 | 365 | 21 | 345 | 18 | 710 | 19 |
| 10–19 | 399 | 27 | 423 | 20 | 822 | 23 | 353 | 2.1 | 320 | 17 | 673 | 19 |
| 20–29 | 77 | 5 | 307 | 15 | 384 | 11 | 277 | 16 | 356 | 19 | 633 | 18 |
| 30–39 | 70 | 5 | 197 | 9 | 267 | 7 | 214 | 13 | 284 | 15 | 498 | 14 |
| 40–49 | 67 | 5 | 152 | 7 | 219 | 6 | 185 | 11 | 207 | 11 | 392 | 11 |
| 50–59 | 61 | 4 | 146 | 7 | 207 | 6 | 143 | 8 | 173 | 9 | 316 | 9 |
| 60–69 | 60 | 4 | 127 | 6 | 187 | 5 | 116 | 7 | 118 | 6 | 234 | 7 |
| 70–79 | 66 | 5 | 86 | 4 | 152 | 4 | 42 | 2 | 46 | 2 | 88 | 2 |
| 80+ | 46 | 3 | 44 | 2 | 90 | 3 | 13 | 1 | 17 | 1 | 30 | 1 |
| Total | ||||||||||||
Overall Disability Prevalence in Cameroon and India.
| Cameroon | India | ||||
|---|---|---|---|---|---|
| n | % (95% CI) | n | % (95% CI) | ||
| Overall Prevalence of Disability | 373 | 10.5 (9.0–12.2) | 437 | 12.2 (10.6–14.1) | |
| Sex | Male | 144 | 9.9 (8.3–11.7) | 199 | 11.7 (9.7–14.0) |
| Female | 229 | 10.8 (9.0–13.0) | 238 | 12.8 (10.9–14.8) | |
| Age Group | 0–17 | 91 | 4.7 (3.7–5.9) | 44 | 3.6 (2.6–4.9) |
| 18–49 | 68 | 6.9 (5.3–9.1) | 137 | 8.1 (6.0–11.0) | |
| 50+ | 214 | 33.6 (28.8–38.9) | 256 | 38.3 (33.6–43.3) | |
Reported Functional Limitations and Clinical Impairments in Cameroon and India.
| Cameroon | India | ||||
|---|---|---|---|---|---|
| n | % (95% CI) | n | % (95% CI) | ||
| Reported Functional Limitations | |||||
| Any Reported Functional Limitation | 197 | 5.9 (4.7–7.4) | 258 | 7.5 (5.9–9.4) | |
| Children 2–17 | Any reported functional limitation | 44 | 2.6 (1.8–3.6) | 25 | 2.3 (1.4–3.7) |
| Seeing | 6 | 0.4 (0.1–0.9) | 3 | 0.3 (0.1–1.2) | |
| Hearing | 6 | 0.4 (0.2–0.8) | 5 | 0.5 (0.2–1.1) | |
| Walking | 13 | 0.8 (0.4–1.5) | 9 | 0.8 (0.4–1.6) | |
| Understanding | 6 | 0.4 (0.2–0.8) | 10 | 0.9 (0.5–1.7) | |
| Being Understood | 7 | 0.4 (0.2–0.9) | 8 | 0.7 (0.3–1.5) | |
| Learning | 11 | 0.6 (0.3–1.2) | 10 | 0.9 (0.4–1.9) | |
| Remembering | 15 | 1.1 (0.6–2.0) | 7 | 0.8 (0.4–1.6) | |
| Self-Care | 4 | 0.3 (0.1–0.8) | 6 | 0.7 (0.3–1.5) | |
| Adults 18+ | Any Reported functional limitation | 153 | 9.5 (7.4–12.1) | 233 | 9.9 (7.9–12.4) |
| Seeing | 48 | 3.0 (2.0–4.3) | 85 | 3.6 (2.4–5.4) | |
| Hearing | 33 | 2.0 (1.3–3.2) | 86 | 3.7 (2.8–4.7) | |
| Walking/climbing | 89 | 5.5 (4.1–7.3) | 112 | 4.8 (3.6–6.2) | |
| Communicating | 7 | 0.4 (0.2–1.0) | 21 | 0.9 (0.6–1.4) | |
| Remembering/ Concentrating | 46 | 2.9 (1.9–4.2) | 31 | 1.3 (0.7–2.4) | |
| Self-Care | 19 | 1.2 (0.7–1.9) | 34 | 1.4 (1.0–2.0) | |
| Upper Body Strength | 19 | 1.2 (0.7–1.9) | 46 | 2.0 (1.5–2.6) | |
| Fine Motor Skills | 14 | 0.9 (0.5–1.5) | 32 | 1.4 (0.8–2.2) | |
| Clinical Impairments | |||||
| Any clinical impairment/ disabling health condition | 294 | 8.4 (7.5–9.4) | 376 | 10.5 (9.4–11.7) | |
| Vision Impairment | All Vision impairment | 82 | 2.3 (1.8–3.0) | 124 | 3.5 (2.7–4.4) |
| Moderate | 55 | 1.9 (1.3–2.6) | 91 | 2.8 (2.2–3.7) | |
| Severe | 10 | 0.3 (0.2–0.6) | 16 | 0.5 (0.3–0.9) | |
| Profound (blind) | 17 | 0.6 (0.3–1.0) | 14 | 0.4 (0.2–0.9) | |
| Hearing Impairment | All Hearing impairment | 127 | 3.6 (2.8–4.6) | 157 | 4.4 (3.7–5.2) |
| Moderate | 76 | 2.5 (1.9–3.2) | 102 | 3.1 (2.4–3.8) | |
| Severe | 15 | 0.5 (0.3–0.8) | 34 | 1.0 (0.7–1.5) | |
| Profound (deaf) | 9 | 0.3 (0.1–0.6) | 15 | 0.5 (0.2–0.9) | |
| Musculoskeletal Impairment | All MSI | 123 | 3.4 (2.7–4.4) | 125 | 3.5 (2.9–4.3) |
| Moderate | 113 | 3.2 (2.5–4.0) | 80 | 2.2 (1.8–2.8) | |
| Severe | 10 | 0.3 (0.2–0.5) | 44 | 1.2 (0.8–1.8) | |
| Health Conditions and Multiple Impairments | Epilepsy | 25 | 0.7 (0.5–1.0) | 63 | 1.8 (1.4–2.2) |
| Clinical Depression (>17 only) | 7 | 0.4 (0.2–0.9) | 26 | 1.1 (0.7–1.6) | |
| Multiple Impairments | 59 | 1.7 (1.2–2.1) | 91 | 2.5 (2.1–3.1) | |
1Table describes proportion of sample reporting “a lot of difficulty” or “cannot do” to any basic domain
* “All” impairment refers to all moderate or greater impairment. Severity estimates for vision and hearing are restricted to >4 and >3 years respectively as severity was not determined below these age groups for each screen
Fig 2Relationship between disability measures in Cameroon and India.
Cross tabulation of clinical severity versus reported limitation.
| None | Mild | Moderate | Severe/Profound | Total | ||
|---|---|---|---|---|---|---|
| India | ||||||
| None | 1769 (90%) | 162 (8%) | 16 (1%) | 10 (1%) | 1957 (100%) | |
| Some | 499 (49%) | 410 (40%) | 82 (8%) | 34 (3%) | 1025 (100%) | |
| A lot/ Can’t do | 12 (5%) | 43 (18%) | 89 (38%) | 92 (39%) | 236 (100%) | |
| Total | 2280 (71%) | 615 (19%) | 187 (6%) | 136 (4%) | 3218 (100%) | |
| Cameroon | ||||||
| None | 1555 (95%) | 52 (3%) | 33 (2%) | 3 (1%) | 1643 (100%) | |
| Some | 790 (68%) | 247 (21%) | 106 (9%) | 16 (1%) | 1159 (100%) | |
| A lot/ Cant do | 28 (18%) | 26 (17%) | 64 (42%) | 35 (23%) | 153 (100%) | |
| Total | 2373 (80%) | 325 (11%) | 203 (7%) | 54 (2%) | 2955 (100%) | |
1Combined cross-tabulation between i) any difficulty seeing, hearing, walking, upper body strength and motor skills and ii) any level visual, hearing or physical impairment. Restricted to age 5 and above based on severity data
2If multiple clinical impairments, most severe used in analysis.
3Cameroon missing hearing severity data for 23 participants excluded from analysis
Odds of reporting a functional limitation amongst participants screening positive for clinical impairments in Cameroon and India.
| Cameroon | India | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Clinical and self-report (n = 118) | Clinical only (n = 168) | Adjusted OR (95% CI) | Clinical and self-report (n = 197) | Clinical only (n = 176) | Adjusted OR (95% CI) | |||||
| n | % | n | % | n | % | n | % | |||
| 2–17 | 20 | 17 | 39 | 23 | 0.9 (0.3–2.7) | 17 | 9 | 17 | 10 | 1.3 (0.6–2.9) |
| 18–33 | 12 | 10 | 17 | 10 | 1.3 (0.4–4.4) | 19 | 9 | 21 | 12 | 1.0 (0.5–2.3) |
| 34–49 | 7 | 6 | 13 | 8 | 31 | 16 | 37 | 21 | ||
| 50–65 | 19 | 16 | 27 | 16 | 1.4 (0.5–4.0) | 72 | 37 | 76 | 43 | 1.1 (0.6–2.0) |
| 66+ | 60 | 51 | 72 | 43 | 1.5 (0.6–4.1) | 60 | 31 | 25 | 14 | 2.9 (1.5–5.7) |
| Male | 50 | 42 | 61 | 36 | 83 | 42 | 90 | 51 | ||
| Female | 68 | 58 | 107 | 64 | 0.8 (0.5–1.2) | 114 | 58 | 86 | 49 | 1.4 (0.9–2.2) |
| Moderate | 73 | 65 | 136 | 90 | 95 | 49 | 108 | 73 | ||
| Severe | 19 | 17 | 9 | 6 | 4.0 (1.7–9.4) | 76 | 39 | 33 | 22 | 2.5 (1.5–4.1) |
| Profound | 20 | 18 | 6 | 6 | 6.2 (2.4–16.3) | 22 | 11 | 7 | 5 | 3.5 (1.4–8.8) |
| Vision | 12 | 10 | 35 | 21 | 28 | 14 | 48 | 28 | ||
| Musculoskeletal | 39 | 33 | 39 | 23 | 3.1 (1.4–7.0) | 41 | 21 | 16 | 9 | 4.8 (2.2–10.4) |
| Hearing | 26 | 22 | 58 | 35 | 1.4 (0.6–3.1) | 52 | 27 | 43 | 25 | 2.1 (1.1–4.0) |
| Epilepsy | 1 | 1 | 16 | 10 | 0.2 (0.1–1.7) | 4 | 2 | 38 | 22 | 0.2 (0.5–0.6) |
| Multiple | 39 | 33 | 19 | 11 | 6.6 (2.7–15.9) | 69 | 36 | 27 | 16 | 4.0 (2.0–7.7) |
1Cameroon: missing severity data for 23 participants excluded; India: missing severity data for 29 participants excluded
2Depression excluded from analysis due to low number (n = 2 Cameroon, n = 7 India)
Participation restrictions amongst people with disabilities in Cameroon and India.
| Cameroon | India | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cat A: self-report only Case | Cat B: Clinical and self-report Case | Cat C: Clinical only Case | Cat A: self-report only Case | Cat B: Clinical and self-report Case | Cat C: Clinical only Case | ||||||||
| Age group | Max score possible | Mean Score | SD | Mean Score | SD | Mean Score | SD | Mean Score | SD | Mean Score | SD | Mean Score | SD |
| Children (5–16) | 60 | 22.1 | 5.7 | 23.3 | 9.5 | 18.3 | 5.2 | 40.0 | 18.2 | 28.6 | 12.2 | 20.7 | 9.9 |
| Adults (17+) | 84 | 26.7 | 13.6 | 38.1 | 13.6 | 31.2 | 9.1 | 36.1 | 15.3 | 45.9 | 16.2 | 34.3 | 11.9 |
*P<0.01 from independent t-test comparing i) Category A vs B and ii) Category B vs C
1NB Higher scores denote greater participation restrictions